- The head of the Seema Network, and founder and publisher of Seema magazine, she joined the lab, engineering, and business facility after nearly two decades at Johnson & Johnson.
Cure, a healthcare innovation campus in New York City, has named Seema Kumar as its new chief executive officer (CEO). An affiliate of Deerfield Management, Cure is a laboratory, engineering, and business facility that brings together industry leaders and innovators across the private and public sectors to advance healthcare through the development of cutting-edge solutions across medical devices, digital technologies, healthcare services, and biotherapeutics.
Kumar, founder of the Seema Network, and founder and publisher of Seema magazine joined her new role today (Oct. 5) after spending nearly two decades at Johnson & Johnson. She most recently served as the company’s Global Head of the Office of Innovation, Global Health and Scientific Engagement.
During her tenure, she led the launch of the company’s Innovation Centers, JLABS and Global Public Health initiatives, as well as the CoLaboratory at the World Economic Forum at Davos and the award-winning COVID-19 educational broadcast program, “The Road to a Vaccine.”
Before that Kumar was chief of staff and chief communications officer at MIT’s Whitehead Institute, playing a leading role in the Human Genome Project and the creation and launch of the Broad Institute.
“I am thrilled and excited to be joining Cure as its CEO and lead the mission to help transform and advance healthcare by continuing to build an active healthcare network and diverse community,” said Kumar in a company press release. “I look forward to working with the team to unlock the power of community, collaboration, content and convening that fulfills the dreams of entrepreneurs, fuels breakthroughs, drives diversity and inclusion, economic growth, and advances healthcare outcomes.”